Rosuvastatin-induced thrombocytopenia
- PMID: 20531065
- DOI: 10.1097/SMJ.0b013e3181e170f5
Rosuvastatin-induced thrombocytopenia
Abstract
Rosuvastatin, a statin indicated for patients with primary hypercholesterolemia, mixed dyslipidemia and familial hypercholesterolemia, is well tolerated by most patients. Its most common adverse effects are gastrointestinal derangement, muscle aches and hepatitis. One rare complication of statin treatment is severe thrombocytopenia. The case of a 65-year-old patient who developed severe thrombocytopenia while on rosuvastatin is presented, in addition to a review of the literature.
Comment in
-
Imperfect pharmacovigilance.South Med J. 2010 Jul;103(7):602-3. doi: 10.1097/SMJ.0b013e3181e24d18. South Med J. 2010. PMID: 20531042 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical